Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."

TSX:TST - Post Discussion

TELESTA THERAPEUTICS INC > Thoughts after listening to today's conference?
View:
Post by SteveMcM on Nov 18, 2015 4:47pm

Thoughts after listening to today's conference?

1) There seemed to be a herd mentallity amongst the committee members. Right off the bat there seemed to be a lack of objectivity when evaluating the drug.

2) Telesta's people really dropped the ball in terms of being able to answer questions be proposed to them. Unprepared is a word that comes to my mind.

3) US revenue was estimated to be 50% of global sales; we still have an opportunity for ex-US approval, and at current prices the stock is cheap compared to those sales estimates

4) The FDA usually follows the advisory committees recommendation when it comes to approving drugs; however in the case of Valstar the FDA approved it three months latet despite of a majority "no vote" by the advisory committee.

5) If the voting question included "for patients who refused bladder removal or patients who were not eligible to receive bladder removal" I wonder how much differently the outcome would have been.

6) I wonder how much of this no vote was influenced by all of the scrutiny being placed on the pharmaceutical industry by democrats. Perhaps they are feeling pressure to vote against drugs to show that they are "fighting back".

Just my take. A disappointing day to say the least.
Comment by ragingbull1327 on Nov 18, 2015 4:56pm
Here are my thoughts about theirs: 1.  Lots of float held by people other than them still.    2. I think they thought a lot more people would SELL on the way up.  They didn't.  It hit $1 on less volume than they had hoped.   3. They drop the price and take profits, and the reason is two-fold.  One, profit taking, because to EVERYONE, that's what it ...more  
Comment by ragingbull1327 on Nov 18, 2015 4:58pm
I'm actually willing to bet MORE on this now after watching that
Comment by rusty4998 on Nov 18, 2015 5:02pm
One problem with your theory, if they knew it was going to be denied then all they'd have to do is buy tomorrow after the vote, no reason to have bought today during the tv show as you put it.
Comment by ragingbull1327 on Nov 18, 2015 5:07pm
YOU THINK TODAYS TRADING WAS BIG MONEY????   Look at the VOLUME.   PEANUTS.  Sure. Way more than average.   But 15 mil / 281 mil on the biggest day in company history is embarrassing.    That's not a big holder buying today bud.  I'm laughing hysterically at my uncle who is now in the red.   Offered to buy his shares (that I can afford) for <21 ...more  
Comment by ragingbull1327 on Nov 18, 2015 5:09pm
Personally, I think somebody is pissed off they missed the first 150% run
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities